pcDNA3.2/V5 hsa-mir-124 Citations (3)

Originally described in: Mammalian microRNAs: experimental evaluation of novel and previously annotated genes.
Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, Blelloch R, Schroth GP, Nusbaum C, Bartel DP Genes Dev. 2010 May 15. 24(10):992-1009. PubMed Journal

---

Articles Citing pcDNA3.2/V5 hsa-mir-124

Articles
Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer. Asuthkar S, Stepanova V, Lebedeva T, Holterman AL, Estes N, Cines DB, Rao JS, Gondi CS. Mol Biol Cell. 2013 Sep;24(17):2620-32. doi: 10.1091/mbc.E12-04-0306. Epub 2013 Jul 17. PubMed
miR-124 represses ROCK1 expression to promote neurite elongation through activation of the PI3K/Akt signal pathway. Gu X, Meng S, Liu S, Jia C, Fang Y, Li S, Fu C, Song Q, Lin L, Wang X. J Mol Neurosci. 2014 Jan;52(1):156-65. doi: 10.1007/s12031-013-0190-6. Epub 2013 Dec 15. PubMed
Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3. Li X, Yang Z, Han Z, Wen Y, Ma Z, Wang Y. Oncol Rep. 2018 Feb;39(2):827-833. doi: 10.3892/or.2017.6146. Epub 2017 Dec 11. PubMed

If you have published an article using this material, please email us at to have your article added to this page.